How can we incorporate molecular data into the IPSS?

Rafael Bejar

doi:10.1016/j.beha.2022.101410

How can we incorporate molecular data into the IPSS?

Best Pract Res Clin Haematol. 2022 Dec;35(4):101410. doi: 10.1016/j.beha.2022.101410. Epub 2022 Nov 1.

Author

Rafael Bejar¹

Affiliation

¹ UC San Diego Moores Cancer Center, 3855 Health Sciences Drive, San Diego, CA, 92093, USA. Electronic address: rabejar@ucsd.edu.

PMID: 36517128
DOI: 10.1016/j.beha.2022.101410

No abstract available

Keywords: AML; Acute myeloid leukemia; Genetic profiling; IPSS-M; IPSS-R; International prognostic scoring system molecular; International prognostic scoring system revised; MDS; Mutations; Myelodysplastic syndromes; Prognostication; Risk stratification.

Publication types

Review

MeSH terms

Humans
Myelodysplastic Syndromes*
Prognosis